GlassScriptPhysician profile
Samer A Ibrahim
NPI 1174843874
$8,431.70
in general payments reported to CMS, 2019-2025
31 companies · $2,766 in 2025
The $2,766 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2021: $121 · 2022: $290 · 2023: $2,311 · 2024: $2,701 · 2025: $2,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,447 · Education: $837 · Travel and Lodging: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,446.67 |
| Education | $837.26 |
| Travel and Lodging | $493.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,200.20 | 2023-2025 | Impella |
| Abbott Laboratories | $1,091.86 | 2019-2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Amgen INC. | $558.22 | 2021-2025 | Repatha |
| Boston Scientific Corporation | $523.18 | 2022-2024 | Watchman Access System, Watchman Flx |
| Medtronic, INC. | $510.10 | 2023-2025 | Onyx Frontier, Corevalve Evolut R, Micra |
| Shockwave Medical, INC | $434.02 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $293.99 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $261.91 | 2025 | |
| Edwards Lifesciences Corporation | $255.88 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Angiodynamics, INC. | $251.05 | 2023-2025 | Auryon Laser System 100-120 Vac |
| Kestra Medical Technology Services, INC. | $238.08 | 2025 | Assure Wcd |
| Penumbra, INC. | $203.75 | 2019-2023 | Indigo System |
| Atricure, INC. | $198.79 | 2024 | |
| Becton, Dickinson and Company | $172.06 | 2025 | |
| Alnylam Pharmaceuticals INC. | $164.94 | 2023-2025 | Amvuttra, Onpattro |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $149.99 | 2025 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.44 | 2024-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $124.44 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Lexicon Pharmaceuticals, INC. | $121.48 | 2023-2024 | Inpefa |
| Novartis Pharmaceuticals Corporation | $89.49 | 2024-2025 | |
| Philips North America LLC | $83.20 | 2024 | (Bq9) Coronary Ivus |
| Pfizer INC. | $71.63 | 2024 | |
| Cardiva Medical, INC. | $56.67 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Terumo Medical Corporation | $50.58 | 2023 | Glidesheath Slender |
| Sanofi-Aventis U.S. LLC | $34.39 | 2024 | |
| Vifor Pharma, INC. | $34.16 | 2023 | Veltassa |
| Bridgebio Pharma, INC. | $28.80 | 2025 | Attruby |
| Actelion Pharmaceuticals US, INC. | $27.00 | 2023 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $26.81 | 2021-2022 | |
| United Therapeutics Corporation | $23.35 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samer Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.